Literature DB >> 25881197

Treatment of Fournier's Gangrene With a Novel Negative Pressure Wound Therapy System .

Jozef Verbelen1, Henk Hoeksema2, Alexander Heyneman2, Ali Pirayesh2, Stan Monstrey3.   

Abstract

UNLABELLED: Fournier's gangrene (FG) is a complex condition that requires surgical debridement, hemodynamic support, antibiotics, and appro- priate wound management. This study is the first to assess the use of a low-vacuum negative pressure wound therapy (LV-NPWT) system with low-adherent contact surface in two cases of FG.
METHODS: The protocol-of-care included twice weekly dressing changes and irrigation with a povidone-iodine-water mixture. Assessments included wound progression (% granulation tissue), ratings of dressing ingrowth, pain during treatment and at dressing changes, patient comfort, and ease- of-use.
RESULTS: A 51-year-old man (Patient A) developed FG after sur- gical removal of a perianal abscess. He received 16 days of LV-NPWT with five dressing changes. A 64-year-old man (Patient B) with multiple comorbidities, developed FG after traumatic injury. He received 20 days of LV-NPWT with six dressing changes. In both patients, LV-NPWT promoted rapid granulation tissue formation. Pain scores averaged low-to-moderate during treatment and dressing changes, and tissue ingrowth was minimal.
CONCLUSION: Overall, ratings were favorable for LV-NPWT ease-of-use and patient comfort. Despite the complexity of these wounds, with the use of LV-NPWT, both wounds progressed to a point where they were able to successfully receive surgical closure with skin grafts and/or flaps. These cases may suggest that LV-NPWT may have a potential role in complex wound management.

Entities:  

Year:  2011        PMID: 25881197

Source DB:  PubMed          Journal:  Wounds        ISSN: 1044-7946            Impact factor:   1.546


  1 in total

Review 1.  Pain and trauma in negative pressure wound therapy: a review.

Authors:  Dominic Upton; Abbye Andrews
Journal:  Int Wound J       Date:  2013-03-12       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.